Stability of famotidine in an extemporaneously compounded oral liquid. 2000

P J Dentinger, and C F Swenson, and N H Anaizi
Department of Pharmacy, Strong Memorial Hospital, Rochester, NY, USA.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D015738 Famotidine A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. Famotidine Hydrochloride,MK-208,Pepcid,YM-11170,MK 208,MK208,YM 11170,YM11170

Related Publications

P J Dentinger, and C F Swenson, and N H Anaizi
November 1993, American journal of hospital pharmacy,
P J Dentinger, and C F Swenson, and N H Anaizi
January 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P J Dentinger, and C F Swenson, and N H Anaizi
February 1994, American journal of hospital pharmacy,
P J Dentinger, and C F Swenson, and N H Anaizi
October 1994, American journal of hospital pharmacy,
P J Dentinger, and C F Swenson, and N H Anaizi
November 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P J Dentinger, and C F Swenson, and N H Anaizi
February 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P J Dentinger, and C F Swenson, and N H Anaizi
August 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P J Dentinger, and C F Swenson, and N H Anaizi
January 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
P J Dentinger, and C F Swenson, and N H Anaizi
April 1993, American journal of hospital pharmacy,
P J Dentinger, and C F Swenson, and N H Anaizi
February 1991, American journal of hospital pharmacy,
Copied contents to your clipboard!